Biovest International, Inc. is a Tampa-based company that specializes in the commercialization of personalized immunotherapies and the development of innovative cell culture and bioreactor systems. With a focus on cancer treatment, their lead product candidate, BiovaxID, has shown promising results in increasing the duration of cancer remission and inducing immune responses correlated with long-term survival.
As a subsidiary of Biovest International, Inc., Cell Culture Company, LLC offers automated single-use perfusion bioreactor systems and custom mammalian cell and protein manufacturing services to customers in the diagnostic, therapeutic, and animal healthcare industries worldwide. The spin-off of Cell Culture Company ensures a dedicated focus on instrument and contract manufacturing, providing enhanced services and solutions to their global clientele.
Generated from the website